Predictive Algorithm Improves Blood Pressure Care

The expectations from the patented technology are a change in the potential relevance of the traditional automated blood pressure measurement, from that of an observational trend measurement to a useful predictive indicator of impending valvular and coronary heart disease (CHD), or cardiac arrest.

The OSTAR 3SI interpretive algorithm is based on customer driven demand and an ongoing commitment to solving heart disease, presenting a cohesive predictive tool to the global clinical and patient world. The company sees the 3SI algorithm as a natural progression in product development, and it will therefore be available in all OSTAR products, with a view to make it available also in the future for original equipment manufacturer (OEM) arrangements, if customer demand dictates.

“Over the long run this form of automated blood pressure algorithm could have an even greater impact than advent interpretive ECG algorithms or AED defibrillators,” said Paul Markham, MBA, PhD, President of V3 Healthcare Strategies (Chicago, IL, USA). “The result is reduced cost to healthcare systems and ultimately, to the American healthcare consumer.”

“This North American launch of OSTAR 3SI algorithm and the following product releases to come set the scene for a change in the overall role of blood pressure measurement globally,” said Doug Hemenway, president and CEO of OSTAR. “Furthermore they are vital steps in OSTAR's commitment to improving patient outcomes while avoiding unnecessary costs, in lockstep with current federal imperatives of Patient Privacy & Accountable Care Act (PPACA).”

Related Links:
Ostar